Page last updated: 2024-10-24

cefuroxime and Premature Birth

cefuroxime has been researched along with Premature Birth in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).

Research Excerpts

ExcerptRelevanceReference
"In combination with roxithromycin, the use of cefuroxime, as a prophylactic in women with premature rupture of membranes at <37 weeks of gestation, showed longer pregnancy in primiparas and less maternal and neonatal morbidity than the use of ampicillin."5.69Compared perinatal outcomes of two prophylactic antibiotic regimens for preterm premature rupture of membranes: a randomized controlled trial. ( Francis, YN; Lowenstein, L; Miron, D; Rechnitzer, H; Sgayer, I; Sheffer, VF; Shprits, E; Wolf, MF, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sgayer, I1
Francis, YN1
Miron, D1
Shprits, E1
Sheffer, VF1
Rechnitzer, H1
Lowenstein, L1
Wolf, MF1

Trials

1 trial available for cefuroxime and Premature Birth

ArticleYear
Compared perinatal outcomes of two prophylactic antibiotic regimens for preterm premature rupture of membranes: a randomized controlled trial.
    American journal of obstetrics & gynecology MFM, 2023, Volume: 5, Issue:5

    Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Female; Fetal Membranes, Premature Rupture; Humans; I

2023